# CISATRACURIUM BESYLATE
> **ANDA212171** · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2019-11-04
## Drug
- **FDA Application Number:** ANDA212171
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CISATRACURIUM BESYLATE
- **Generic name:** CISATRACURIUM BESYLATE
- **Active ingredients:** CISATRACURIUM BESYLATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** ZYDUS PHARMS
- **Manufacturer:** Zydus Lifesciences Limited
- **First approval:** 2019-11-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212171)
---
*AI Analytics · CC0 1.0*